LianBio Market Cap

LianBio has a market cap or net worth of $30.09 million as of April 26, 2024. Its market cap has decreased by -82.42% in one year.

Market Cap

30.09M

Enterprise Value

-219.29M

1-Year Change

-82.42%

Ranking

n/a

Market Cap Chart

Since the IPO on November 1, 2021, LianBio's market cap has decreased from $1.68B to $30.09M, a decrease of -98.21%. That is a compound annual growth rate of -81.59%.

Market Cap History

Date	Market Cap	% Change
Mar 18, 2024	34.50M	-8.24%
Mar 15, 2024	37.60M	-93.03%
Mar 14, 2024	539.20M	0.80%
Mar 13, 2024	534.90M	-
Mar 12, 2024	534.90M	0.60%
Mar 11, 2024	531.70M	-0.19%
Mar 8, 2024	532.70M	0.60%
Mar 7, 2024	529.50M	-0.81%
Mar 6, 2024	533.80M	0.39%
Mar 5, 2024	531.70M	0.62%
Mar 4, 2024	528.40M	0.21%
Mar 1, 2024	527.30M	0.82%
Feb 29, 2024	523.00M	0.40%
Feb 28, 2024	520.90M	0.12%
Feb 27, 2024	520.30M	0.10%
Feb 26, 2024	519.80M	0.43%
Feb 23, 2024	517.60M	-
Feb 22, 2024	517.60M	-
Feb 21, 2024	517.60M	-
Feb 20, 2024	517.60M	0.41%
Feb 16, 2024	515.50M	-0.19%
Feb 15, 2024	516.50M	0.41%
Feb 14, 2024	514.40M	-0.83%
Feb 13, 2024	518.70M	18.80%
Feb 12, 2024	436.60M	-2.41%

View and export this data all the way back to 2021. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Eli Lilly	697.40B
Novo Nordisk	550.22B
UnitedHealth Group	456.68B
Johnson & Johnson	352.17B
Merck & Co.	332.28B
AbbVie	282.63B
AstraZeneca	233.01B
Thermo Fisher	218.95B

Market Cap Rankings